Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics

CompletedOBSERVATIONAL
Enrollment

158

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Schizophrenia
Trial Locations (37)

Unknown

Research Site, Alphen

Research Site, Amersfoort

Research Site, Amstelveen

Research Site, Amsterdam

Research Site, Arnhem

Research Site, Bennebroek

Research Site, Boxmeer

Research Site, Breda

Research Site, Doetinchem

Research Site, Echt

Research Site, Enkhuizen

Research Site, Enschede

Research Site, Haarlem

Research Site, Halsteren

Research Site, Helmond

Research Site, Heythuysen

Research Site, Hoorn

Research Site, Kerkrade

Research Site, Kloetinge

Research Site, Leeuwarden

Research Site, Maastricht

Research Site, Nijmegen

Research Site, Oegstgeest

Research Site, Raalte

Research Site, Roermond

Research Site, Rotterdam

Research Site, Sluis

Research Site, Tiel

Research Site, Tilburg

Research Site, Utrecht

Research Site, Veenendaal

Research Site, Venray

Research Site, Vlaardingen

Research Site, Weert

Research Site, Zaandam

Research Site, Zoetermeer

Research Site, Zwolle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY